ArticleFrontiers in oncology2025
Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma.
Ângela Marques-Magalhães et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2025
this papercites it